Clinical Trial: A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: An Open Label Study to Evaluate the Safety and Efficacy of 12 Week Treatment With CFZ533 in Patients With Graves' Disease

Brief Summary: An open label study to evaluate the safety and efficacy of CFZ533 following 12 weeks treatment in patients with Graves' disease